Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Ollmann Saphire

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
Science (New York, N.Y.)|September 10, 2016
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesAnna Z Wec, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Antiviral Research|March 20, 2023
SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse modelRubens Prince Dos Santos Alves, Ying-Ting Wang, Zbigniew Mikulski, et al.
Cell Host & Microbe|January 28, 2023
Structure of the Inmazeb cocktail and resistance to Ebola virus escapeVamseedhar Rayaprolu, Benjamin O Fulton, Ashique Rafique, et al.
Cell|January 26, 2016
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus InfectionAndrew I Flyak, Xiaoli Shen, Charles D Murin, et al.
Journal of Virology|October 16, 2015
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan VirusesFrederick W Holtsberg, Sergey Shulenin, Hong Vu, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Stabilized Full-Length Measles Fusion Protein Elicits Potent Immunity and Protection In VivoDawid S Zyla, Gillian Zipursky, Roberta Della Marca, et al.
Nature Communications|October 3, 2022
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concernMatthew R Chang, Luke Tomasovic, Natalia A Kuzmina, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Immunity|April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virusBronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
Research Square|February 23, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationGalit Alter, Matthew Gorman, Nita Patel, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
Science (New York, N.Y.)|September 10, 2016
A "Trojan horse" bispecific-antibody strategy for broad protection against ebolavirusesAnna Z Wec, Elisabeth K Nyakatura, Andrew S Herbert, et al.
Antiviral Research|March 20, 2023
SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse modelRubens Prince Dos Santos Alves, Ying-Ting Wang, Zbigniew Mikulski, et al.
Cell Host & Microbe|January 28, 2023
Structure of the Inmazeb cocktail and resistance to Ebola virus escapeVamseedhar Rayaprolu, Benjamin O Fulton, Ashique Rafique, et al.
Cell|January 26, 2016
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus InfectionAndrew I Flyak, Xiaoli Shen, Charles D Murin, et al.
Journal of Virology|October 16, 2015
Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan VirusesFrederick W Holtsberg, Sergey Shulenin, Hong Vu, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Stabilized Full-Length Measles Fusion Protein Elicits Potent Immunity and Protection In VivoDawid S Zyla, Gillian Zipursky, Roberta Della Marca, et al.
Nature Communications|October 3, 2022
IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concernMatthew R Chang, Luke Tomasovic, Natalia A Kuzmina, et al.
Cell Reports|April 8, 2023
Systematic analysis of human antibody response to ebolavirus glycoprotein shows high prevalence of neutralizing public clonotypesElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Immunity|April 14, 2021
A Fc engineering approach to define functional humoral correlates of immunity against Ebola virusBronwyn M Gunn, Richard Lu, Matthew D Slein, et al.
Research Square|February 23, 2021
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccinationGalit Alter, Matthew Gorman, Nita Patel, et al.
Pageof 22